S&P 500   5,005.77 (-0.11%)
DOW   37,986.71 (+0.56%)
QQQ   419.10 (-1.02%)
AAPL   165.24 (-1.08%)
MSFT   400.87 (-0.84%)
META   486.86 (-2.98%)
GOOGL   154.62 (-0.89%)
AMZN   176.16 (-1.71%)
TSLA   149.13 (-0.53%)
NVDA   817.73 (-3.42%)
AMD   150.76 (-2.79%)
NIO   3.86 (-3.50%)
BABA   68.70 (-0.26%)
T   16.39 (+0.37%)
F   12.09 (+0.25%)
MU   109.05 (-2.57%)
GE   150.94 (-1.31%)
CGC   7.55 (-3.58%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.56 (+0.67%)
PYPL   62.04 (-0.10%)
XOM   120.52 (+1.69%)
S&P 500   5,005.77 (-0.11%)
DOW   37,986.71 (+0.56%)
QQQ   419.10 (-1.02%)
AAPL   165.24 (-1.08%)
MSFT   400.87 (-0.84%)
META   486.86 (-2.98%)
GOOGL   154.62 (-0.89%)
AMZN   176.16 (-1.71%)
TSLA   149.13 (-0.53%)
NVDA   817.73 (-3.42%)
AMD   150.76 (-2.79%)
NIO   3.86 (-3.50%)
BABA   68.70 (-0.26%)
T   16.39 (+0.37%)
F   12.09 (+0.25%)
MU   109.05 (-2.57%)
GE   150.94 (-1.31%)
CGC   7.55 (-3.58%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.56 (+0.67%)
PYPL   62.04 (-0.10%)
XOM   120.52 (+1.69%)
S&P 500   5,005.77 (-0.11%)
DOW   37,986.71 (+0.56%)
QQQ   419.10 (-1.02%)
AAPL   165.24 (-1.08%)
MSFT   400.87 (-0.84%)
META   486.86 (-2.98%)
GOOGL   154.62 (-0.89%)
AMZN   176.16 (-1.71%)
TSLA   149.13 (-0.53%)
NVDA   817.73 (-3.42%)
AMD   150.76 (-2.79%)
NIO   3.86 (-3.50%)
BABA   68.70 (-0.26%)
T   16.39 (+0.37%)
F   12.09 (+0.25%)
MU   109.05 (-2.57%)
GE   150.94 (-1.31%)
CGC   7.55 (-3.58%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.56 (+0.67%)
PYPL   62.04 (-0.10%)
XOM   120.52 (+1.69%)
S&P 500   5,005.77 (-0.11%)
DOW   37,986.71 (+0.56%)
QQQ   419.10 (-1.02%)
AAPL   165.24 (-1.08%)
MSFT   400.87 (-0.84%)
META   486.86 (-2.98%)
GOOGL   154.62 (-0.89%)
AMZN   176.16 (-1.71%)
TSLA   149.13 (-0.53%)
NVDA   817.73 (-3.42%)
AMD   150.76 (-2.79%)
NIO   3.86 (-3.50%)
BABA   68.70 (-0.26%)
T   16.39 (+0.37%)
F   12.09 (+0.25%)
MU   109.05 (-2.57%)
GE   150.94 (-1.31%)
CGC   7.55 (-3.58%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.56 (+0.67%)
PYPL   62.04 (-0.10%)
XOM   120.52 (+1.69%)

Compare Stocks

No chart data

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
$0.00
$12.81
$13.82
N/AN/A24,050 shsN/A
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
$0.48
$0.00
$1.69
$14.81
$1.17MN/A102,599 shs176,741 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
3.00
Buy$50.00∞ Upside
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/AN/AN/AN/A
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/AN/AN/A
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/A
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
N/A

Insider Ownership

CompanyInsider Ownership
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/A
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Federated Enhanced Treasury Income Fund stock logo
FTT
Federated Enhanced Treasury Income Fund
N/AN/AN/ANot Optionable
Hemispherx BioPharma, Inc stock logo
HEB
Hemispherx BioPharma
312.44 millionN/ANot Optionable

HEB, FIJ, FTT, and RAC Headlines

SourceHeadline
Hemispherx BioPharma (NYSEAMERICAN:HEB) Shares Cross Above 200 Day Moving Average of $0.00Hemispherx BioPharma (NYSEAMERICAN:HEB) Shares Cross Above 200 Day Moving Average of $0.00
americanbankingnews.com - April 17 at 2:58 AM
H-E-B to donate sauces to every Meals on Wheels of Odessa clientH-E-B to donate sauces to every Meals on Wheels of Odessa client
oaoa.com - January 17 at 7:53 PM
H-E-B hosting hiring fairsH-E-B hosting hiring fairs
cbsnews.com - January 7 at 7:06 PM
H-E-B bets on loyal customers as it expands affordable Joe V’s storesH-E-B bets on loyal customers as it expands affordable Joe V’s stores
chron.com - October 3 at 6:01 PM
Road rage incident leads to stabbing at H-E-BRoad rage incident leads to stabbing at H-E-B
kens5.com - September 27 at 8:45 AM
H-E-B announces new stores in Prosper, Melissa, RockwallH-E-B announces new stores in Prosper, Melissa, Rockwall
nbcdfw.com - September 25 at 7:28 PM
How H-E-B rewrote the retail playbookHow H-E-B rewrote the retail playbook
therealdeal.com - September 10 at 2:56 PM
H-E-B enters the film world with a five-part docuseries covering Texas parks and wildlifeH-E-B enters the film world with a five-part docuseries covering Texas parks and wildlife
chron.com - August 28 at 6:36 PM
Novel Drugs Targeting Toll-like Receptors for Antiviral TherapyNovel Drugs Targeting Toll-like Receptors for Antiviral Therapy
medscape.com - July 23 at 12:58 PM
Former H-E-B to become Tesla showroom, filings showFormer H-E-B to become Tesla showroom, filings show
statesman.com - July 20 at 12:34 AM
Heres what happened to H-E-Bs video rental store you forgot aboutHere's what happened to H-E-B's video rental store you forgot about
mysanantonio.com - July 10 at 7:43 PM
H-E-B opens doors to new Georgetown grocery storeH-E-B opens doors to new Georgetown grocery store
bizjournals.com - July 1 at 1:09 PM
H-E-B should bring commercials back for No. 1 NBA Draft pick WembanyamaH-E-B should bring commercials back for No. 1 NBA Draft pick Wembanyama
mysanantonio.com - June 29 at 8:53 PM
Hemispherxs Ampligen Dealt FDA BlowHemispherx's Ampligen Dealt FDA Blow
thestreet.com - June 27 at 11:56 PM
H-E-B celebrates Corpus Christi educators with the 2023 H-E-B Excellence in Education awardsH-E-B celebrates Corpus Christi educators with the 2023 H-E-B Excellence in Education awards
kristv.com - May 4 at 11:43 PM
What is Mi Tienda? We took a tour of H-E-Bs Mexican grocery storeWhat is Mi Tienda? We took a tour of H-E-B's Mexican grocery store
houstonchronicle.com - April 28 at 9:39 AM
H-E-B opens first Fresh Bites convenience store in Central TexasH-E-B opens first Fresh Bites convenience store in Central Texas
mysanantonio.com - April 25 at 8:06 PM
H-E-B heir back on Forbes billionaires list, Elon Musk falls from topH-E-B heir back on Forbes billionaires list, Elon Musk falls from top
mysanantonio.com - April 15 at 7:42 PM
H-E-B crowned ultimate Texas brand in online competitionH-E-B crowned ultimate Texas brand in online competition
beaumontenterprise.com - April 3 at 9:32 AM
B&H Photo promo code for March 2023B&H Photo promo code for March 2023
pcgamer.com - March 30 at 2:50 PM
YS Biopharma Down 38%; Reports Favorable Covid-19 Vaccine ResultsYS Biopharma Down 38%; Reports Favorable Covid-19 Vaccine Results
marketwatch.com - March 29 at 7:53 PM
Here are five H-E-B products Texans love, as recommended by readersHere are five H-E-B products Texans love, as recommended by readers
houstonchronicle.com - March 22 at 1:48 AM
First Wave BioPharma Shares Rise 9% After Dosing First Patient With AdrulipaseFirst Wave BioPharma Shares Rise 9% After Dosing First Patient With Adrulipase
marketwatch.com - March 11 at 11:52 PM
H-E-B is hiring hundreds of workers for its newest North Texas grocery storeH-E-B is hiring hundreds of workers for its newest North Texas grocery store
star-telegram.com - February 26 at 3:11 PM

Media Sentiment Over Time

Company Descriptions

Federated Enhanced Treasury Income Fund logo

Federated Enhanced Treasury Income Fund

NYSE:FTT
Federated Premier Intermediate Municipal Income Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income tax, including the federal alternative minimum tax (AMT). The Fund's portfolio of investments include various sectors namely transportation, special tax, hospital, education, public power, senior care, water and sewer, general obligation-local, industrial development bond/pollution control revenue and general obligation-state. The Fund invests in intermediate-term, tax-exempt municipal bonds diversified among states, sectors and issuers. Federated Investment Management Company is the advisor of the Fund.
Hemispherx BioPharma logo

Hemispherx BioPharma

NYSEAMERICAN:HEB
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of CFS, Hepatitis B, HIV, and cancer patients with renal cell carcinoma and malignant melanoma. The company was founded in 1990 and is headquartered in Orlando, Florida.